We are live on !
Find out more
Capricorn Fund Managers Portfolio holdings
AUM
$1.06B
Turnover
60.18%
1-Year Est. Return
45.98%
This Fund
S&P 500
This Quarter Est. Return
+0.64%
1 Year Est. Return
+45.98%
3 Year Est. Return
+173.07%
5 Year Est. Return
+199.84%
10 Year Est. Return
–
AUM
$1.06B
AUM Growth
-$209M
(-16%)
Cap. Flow
-$159M
Cap. Flow % of AUM
Cap. Flow %
-14.98%
Top 10 Holdings %
Top 10 Hldgs %
26.39%
Holding
226
New
48
Increased
41
Reduced
36
Closed
88
Avg Time Held
Equity + Options
0.5
years
Top 10 Avg Time Held
Equity + Options
0.2
years
Top 20 Avg Time Held
Equity + Options
0.1
years
Avg Time Held Equity only
0.6
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lincoln National
LNC
|
+$35M |
| 2 |
Xenon Pharmaceuticals
XENE
|
+$32.5M |
| 3 |
Citigroup
C
|
+$27.6M |
| 4 |
Roivant Sciences
ROIV
|
+$18M |
| 5 |
Nokia
NOK
|
+$17.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KKR & Co
KKR
|
+$44.8M |
| 2 |
LPL Financial
LPLA
|
+$36.5M |
| 3 |
BP
BP
|
+$35.8M |
| 4 |
Applovin
APP
|
+$31.6M |
| 5 |
ING
ING
|
+$28.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 27.28% |
| 2 | Healthcare | 19.33% |
| 3 | Consumer Discretionary | 16.88% |
| 4 | Technology | 15.98% |
| 5 | Consumer Staples | 6.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Vita Coco
COCO
$3.6B
| $8.36M | 0.79% |
146,000
+131,000
| +873% | +$8.32M |
2026 Q1
2 quarters
|
|
52
Brinker International
EAT
$8.24B
| $8.32M | 0.79% |
43,000
+3,000
| +8% | +$633K |
2026 Q1
2 quarters
|
|
53
Boost Run Inc
BRUN
$440M
| $8.25M | 0.78% |
500,000
-250,000
| -33% | -$5.13M |
2026 Q2
1 quarter
|
|
54
Boot Barn
BOOT
$4.12B
| $7.95M | 0.75% |
66,000
+25,500
| +63% | +$3.83M |
2026 Q2
1 quarter
|
|
55
Dollar General
DG
$29.6B
| $7.35M | 0.69% |
+61,500
| New | +$7.58M |
2026 Q3
0 quarters
|
|
56
Waters Corp
WAT
$90.5B
| $7.29M | 0.69% |
+16,599
| New | +$6.65M |
2026 Q3
0 quarters
|
|
57
SPDR Gold Trust
GLD
$130B
| $6.89M | 0.65% |
+18,100
| New | +$7.08M |
2026 Q3
0 quarters
|
|
|
58
BP
BP
$118B
| $6.6M | 0.62% |
150,000
-834,203
| -85% | -$35.8M |
2026 Q2
1 quarter
|
|
59
NatWest
NWG
$62.5B
| $6.47M | 0.61% |
356,200
-231,090
| -39% | -$4.26M |
2026 Q2
1 quarter
|
|
60
Tapestry
TPR
$26B
| $6.33M | 0.6% |
55,000
+13,000
| +31% | +$1.74M |
2026 Q1
2 quarters
|
|
61
AbbVie
ABBV
$521B
| $6.26M | 0.59% |
23,926
-3,471
| -13% | -$890K |
2026 Q1
2 quarters
|
|
62
Charles River Laboratories
CRL
$16.2B
| $6.19M | 0.58% |
20,997
-10,277
| -33% | -$2.71M |
2026 Q2
1 quarter
|
|
63
Capital One
COF
$117B
| $5.88M | 0.55% |
30,450
-20,136
| -40% | -$4.23M |
2026 Q2
1 quarter
|
|
64
Visa
V
$794B
| $5.78M | 0.55% |
16,079
-4,476
| -22% | -$1.64M |
2022 Q2
17 quarters
|
|
65
Diageo
DEO
$56.6B
| $5.74M | 0.54% |
67,000
+13,000
| +24% | +$1.14M |
2026 Q1
2 quarters
|
|
66
LuxExperience B.V.
LUXE
$1.47B
| $5.64M | 0.53% |
568,324
-342,048
| -38% | -$2.78M |
2024 Q4
7 quarters
|
|
67
Flagstar Bank National Association
FLG
$4.17B
| $5.59M | 0.53% |
479,000
+80,800
| +20% | +$1.11M |
2026 Q2
1 quarter
|
|
68
Encompass Health
EHC
$13.8B
| $5.02M | 0.47% |
41,326
+22,982
| +125% | +$2.71M |
2026 Q2
1 quarter
|
|
69
Ross Stores
ROST
$74B
| $4.79M | 0.45% |
20,536
+2,036
| +11% | +$478K |
2026 Q1
2 quarters
|
|
70
Rhythm Pharmaceuticals
RYTM
$7.97B
| $4.78M | 0.45% |
+50,166
| New | +$5.35M |
2026 Q3
0 quarters
|
|
71
Zegna
ZGN
$3.71B
| $4.75M | 0.45% |
+380,000
| New | +$5.11M |
2026 Q3
0 quarters
|
|
72
Deckers Outdoor
DECK
$11.6B
| $4.69M | 0.44% |
60,000
+6,000
| +11% | +$553K |
2026 Q1
2 quarters
|
|
73
Pacific Biosciences
PACB
$612M
| $4.58M | 0.43% |
+1,932,623
| New | +$2.73M |
2026 Q3
0 quarters
|
|
74
Linde
LIN
$242B
| $4.41M | 0.42% |
9,279
+2,941
| +46% | +$1.45M |
2023 Q3
12 quarters
|
|
75
Pfizer
PFE
$165B
| $4.12M | 0.39% |
144,568
+122,438
| +553% | +$3.26M |
2025 Q4
3 quarters
|
|
Similar funds
Capricorn Fund Managers's Q3 2026 Portfolio in Review
As of Q3 2026, Capricorn Fund Managers held 226 positions worth $1.06B, down 16% from $1.27B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Capricorn Fund Managers withdrew a net $159M in Q3 2026, closing 88 positions and reducing 36 holdings. Its most notable exit was Applovin, an estimated $31.6M position sold in full.
By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Capricorn Fund Managers opened a new position in Lincoln National worth $33M.
- Capricorn Fund Managers's largest Q3 2026 buy was Lincoln National: 820,000 shares worth $33M.
- Capricorn Fund Managers added most to Xenon Pharmaceuticals in Q3 2026, an estimated $32.5M increase.
- Capricorn Fund Managers's biggest Q3 2026 reduction was KKR & Co, cutting an estimated $44.8M.
- Capricorn Fund Managers fully exited Applovin in Q3 2026, selling an estimated $31.6M.
- Capricorn Fund Managers's ten largest holdings make up 26% of its $1.06B portfolio in Q3 2026.
- Capricorn Fund Managers opened 48 new positions and closed 88 in Q3 2026.
- Capricorn Fund Managers's portfolio value fell 16% quarter-over-quarter to $1.06B.
Based on Capricorn Fund Managers's 13F filing for Q3 2026, filed 3 Nov 2026.